Stelara 90 MG/ML syringeml

Ended Awarded Last action

Contract number
SPE2DR26FHKA2
Awardee
Awarding agency
Obligated
$16,584

Award facts

Contract value 100% obligated
$16,584.13 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, for $16,584.13 to supply Stelara 90 mg/ml syringes under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency program authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. Place of performance is Park Ridge, IL. The ultimate completion date is March 17, 2026.

Quick answers

Who was awarded contract SPE2DR26FHKA2?

SPE2DR26FHKA2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 24, 2026.

How much is contract SPE2DR26FHKA2 worth?

The government has obligated $16,584 on SPE2DR26FHKA2.

Is contract SPE2DR26FHKA2 an order under another contract?

Yes. SPE2DR26FHKA2 is a delivery order under SPE2DR25D9218, an indefinite delivery contract.

Was contract SPE2DR26FHKA2 competed?

The extent of competition for SPE2DR26FHKA2 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award